Wangrui Lei

817 total citations · 1 hit paper
33 papers, 497 citations indexed

About

Wangrui Lei is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Wangrui Lei has authored 33 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Infectious Diseases. Recurrent topics in Wangrui Lei's work include Phagocytosis and Immune Regulation (7 papers), COVID-19 Clinical Research Studies (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Wangrui Lei is often cited by papers focused on Phagocytosis and Immune Regulation (7 papers), COVID-19 Clinical Research Studies (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Wangrui Lei collaborates with scholars based in China and United States. Wangrui Lei's co-authors include Yang Yang, Chao Deng, Chenxi Lu, Wenwen Yang, Zhenxiao Jin, Mingzhi Shen, Huadong Zhao, Meng Sun, Zhi Yang and Yunfeng Ni and has published in prestigious journals such as Free Radical Biology and Medicine, Biochemical Pharmacology and European Journal of Pharmacology.

In The Last Decade

Wangrui Lei

29 papers receiving 493 citations

Hit Papers

CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Cli... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wangrui Lei China 14 186 146 83 67 63 33 497
Shinsuke Chida Japan 5 179 1.0× 155 1.1× 55 0.7× 62 0.9× 88 1.4× 7 522
Gareth S. D. Purvis United Kingdom 11 251 1.3× 174 1.2× 56 0.7× 36 0.5× 63 1.0× 17 469
Xiaolan Li China 13 171 0.9× 94 0.6× 37 0.4× 42 0.6× 66 1.0× 52 505
Graziele L. Negreiros-Lima Brazil 10 190 1.0× 204 1.4× 49 0.6× 73 1.1× 44 0.7× 10 485
Yi‐yuan Li China 10 275 1.5× 176 1.2× 58 0.7× 41 0.6× 61 1.0× 17 597
Fei Xiong China 15 340 1.8× 148 1.0× 76 0.9× 121 1.8× 80 1.3× 39 766
Sipin Tan China 14 336 1.8× 96 0.7× 37 0.4× 72 1.1× 81 1.3× 40 510
Liza U. Ljungberg Sweden 11 169 0.9× 137 0.9× 91 1.1× 46 0.7× 63 1.0× 29 593
Kátia M. Lima Brazil 12 264 1.4× 282 1.9× 66 0.8× 90 1.3× 61 1.0× 13 663

Countries citing papers authored by Wangrui Lei

Since Specialization
Citations

This map shows the geographic impact of Wangrui Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wangrui Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wangrui Lei more than expected).

Fields of papers citing papers by Wangrui Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wangrui Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wangrui Lei. The network helps show where Wangrui Lei may publish in the future.

Co-authorship network of co-authors of Wangrui Lei

This figure shows the co-authorship network connecting the top 25 collaborators of Wangrui Lei. A scholar is included among the top collaborators of Wangrui Lei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wangrui Lei. Wangrui Lei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Yang, Jiayan Li, Jiayou Tang, et al.. (2025). CCL2-CCR2 axis in cardiovascular disease: research advances and challenges. Science Bulletin. 70(6). 820–824.
2.
Wang, Bodong, Aizhen Zhao, Ning Li, et al.. (2025). Pleiotropic role of mGluR7/MAPK signaling in the protection of intelectin-1 against cerebral ischemia-reperfusion injury. Pharmacological Research. 216. 107735–107735. 1 indexed citations
3.
Ren, Yushan, et al.. (2025). Prospects and Challenges of Catechins in Cardiovascular Disease. The AAPS Journal. 27(5). 119–119.
4.
Liu, Hai, Wangrui Lei, Dashuai Wang, et al.. (2025). Protective effects of Ginkgolide B on myocardial ischemia reperfusion injury: role of the GAS6/Axl signaling pathway. Chemico-Biological Interactions. 418. 111607–111607. 1 indexed citations
5.
Lu, Chenxi, Yanbin Song, Xiaopeng Wu, et al.. (2024). Pleiotropic role of GAS6 in cardioprotection against ischemia-reperfusion injury. Journal of Advanced Research. 70. 481–497. 4 indexed citations
6.
Li, Jiayan, Yan Zhang, Hui Liu, et al.. (2024). Glycogen synthase kinase‐3β: A multifaceted player in ischemia‐reperfusion injury and its therapeutic prospects. Journal of Cellular Physiology. 239(9). e31335–e31335. 8 indexed citations
7.
Zhang, Zhe, Xiaopeng Wu, Mingzhi Shen, et al.. (2024). Heat stroke: Pathogenesis, diagnosis, and current treatment. Ageing Research Reviews. 100. 102409–102409. 21 indexed citations
8.
Dong, Yushu, Jiayou Tang, Zhenxiao Jin, et al.. (2024). FPR1: A critical gatekeeper of the heart and brain. Pharmacological Research. 202. 107125–107125. 13 indexed citations
9.
Zhao, Aizhen, Xiaopeng Wu, Xin Zhang, et al.. (2024). Identifying and validating potential therapeutic targets for septic heart failure and the cardioprotective effects of lycorine. Phytomedicine. 129. 155677–155677. 1 indexed citations
10.
Wu, Xue, Zheng Wang, Zibin Liang, et al.. (2024). Pleiotropic role of CCR9/CCL25 signaling in adriamycin-induced cardiomyopathy. Journal of Advanced Research. 75. 707–722. 1 indexed citations
11.
Wang, Zheng, Wangrui Lei, Mingzhi Shen, et al.. (2023). Pentraxin 3: A promising therapeutic target for cardiovascular diseases. Ageing Research Reviews. 93. 102163–102163. 15 indexed citations
12.
Di, Wencheng, Zhe Zhang, Ning Li, et al.. (2023). Activation of ITLN‐1 attenuates oxidative stress injury via activating SIRT1/PGC1‐α signaling in neuroblastoma cells. Journal of Cellular Physiology. 239(1). 67–78. 4 indexed citations
13.
Di, Wencheng, Zhenxiao Jin, Wangrui Lei, et al.. (2023). Protection of melatonin treatment and combination with traditional antibiotics against septic myocardial injury. Cellular & Molecular Biology Letters. 28(1). 35–35. 13 indexed citations
14.
Yang, Yaru, Wangrui Lei, Haiying Wang, et al.. (2023). CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications. International Journal of Biological Sciences. 19(11). 3341–3359. 102 indexed citations breakdown →
15.
Wang, Daquan, Huadong Zhao, Chao Deng, et al.. (2023). Sulfide-modified nanoscale zero-valent iron as a novel therapeutic remedy for septic myocardial injury. Journal of Advanced Research. 55. 145–158. 5 indexed citations
16.
Ji, Ting, Qiong Liu, Liming Yu, et al.. (2023). GAS6 attenuates sepsis-induced cardiac dysfunction through NLRP3 inflammasome-dependent mechanism. Free Radical Biology and Medicine. 210. 195–211. 14 indexed citations
17.
Lei, Wangrui, Songdi Wu, Aizhen Zhao, et al.. (2022). Psoralidin protects against cerebral hypoxia/reoxygenation injury: Role of GAS6 /Axl signaling. Phytotherapy Research. 36(6). 2628–2640. 14 indexed citations
18.
Wang, Daquan, Changyu Wang, Zhenxing Liang, et al.. (2022). Protection of zero-valent iron nanoparticles against sepsis and septic heart failure. Journal of Nanobiotechnology. 20(1). 405–405. 18 indexed citations
19.
Lei, Wangrui, Yan Xu, Min Zhang, et al.. (2021). Abnormal hippocampal substructure volume in insomnia disorder. Brain Imaging and Behavior. 16(2). 672–679. 5 indexed citations
20.
Wang, Zheng, Wenying Zhou, Chenxi Lu, et al.. (2021). SIRT1/PGC-1α signaling activation by mangiferin attenuates cerebral hypoxia/reoxygenation injury in neuroblastoma cells. European Journal of Pharmacology. 907. 174236–174236. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026